(Q45472170)

14 December 2017

title

Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation (English)

1 reference

14 December 2017

0 references

1 reference

2

1 reference

14 December 2017

Robert F Wynn

1

0 references

author name string

Tanzina Haque

3

1 reference

14 December 2017

Maged I Gharib

4

1 reference

14 December 2017

Gwen Wilkie

5

1 reference

14 December 2017

Marie Morton-Jones

6

1 reference

14 December 2017

Dorothy H Crawford

7

1 reference

14 December 2017

publication date

1 May 2005

1 reference

Lancet Oncology Commission

14 December 2017

published in

1 reference

14 December 2017

volume

6

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

344-346

1 reference

Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of epstein-barr virus-associated diseases

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

Recent advances in primary CNS lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2805%2970171-6

7 January 2021

10.1016/S1470-2045(05)70171-6

Identifiers

DOI

1 reference

14 December 2017

1 reference